Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works
- Written by Mark R. O'Brian, Professor and Chair of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Moderna is testing an mRNA vaccine in combination with pembrolizumab to treat melanoma.Javier Zayas Photography/Moment via Getty ImagesMediaoutlets have reported the encouraging findings of clinical trials for a new experimental vaccine developed by the biotech company Moderna to treat an aggressive type of skin cancer called melanoma.
Although...





